AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral TherapyComplementary and Alternative Therapies for CancerPrognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic reviewSeptember 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating AgentsComparative effectiveness research in oncologyCalcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical reviewAre we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Carcinoid tumorsThe role of Src in solid tumorsFOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceBRCAness: finding the Achilles heel in ovarian cancerCapecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancerRole of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataThe benefit of the neutropenic diet: fact or fiction?The role of RANK-ligand inhibition in cancer: the story of denosumabThe European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for humContagious cancerIsolated limb perfusion for malignant melanoma: systematic review on effectiveness and safetyTherapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in JapanMolecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission TomographyThe role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agentsIpilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanomaAdvancing cervical cancer prevention in India: implementation science prioritiesThyroid lymphoma: recent advances in diagnosis and optimal management strategiesNovel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancerSorafenib in metastatic thyroid cancer: a systematic reviewTime course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyMore than just skin deep: faciocutaneous clues to genetic syndromes with malignanciesReview and uses of stereotactic body radiation therapy for oligometastasesUse of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancerOverview and management of cardiac adverse events associated with tyrosine kinase inhibitorsThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careThe evolution of the locoregional therapy of breast cancerSystematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanomaSecond-Line Therapy for Advanced NSCLCBendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient managementCancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysisEuropean perspective on multiple myeloma treatment strategies in 2014Practical management of bevacizumab-related toxicities in glioblastoma
P1433
Q22241462-F5ECC412-BD92-4BA4-80FB-FC752D105B1CQ22241463-881A7FF6-2B31-498D-BC16-9760572247B0Q22305894-E0C44D08-5C4D-4C29-993E-92355FC1C046Q22305895-F3A55B4E-9CBB-4EB6-990D-9BB4EBF0135DQ24282586-5B0A569E-E91F-4D5E-9E3E-0BF76E08B1B0Q24597422-279FF391-1668-4855-84B5-77362372B25EQ24597424-9FEDCD80-7273-4291-A79E-E73E09D9591FQ24614827-08D3143F-6E60-4784-961F-527671ACFE63Q24616659-768CE5EF-753D-4CB4-AE17-12F087EFD939Q24622390-41D20D75-DCD9-44D6-A6F6-5CAACDC6754DQ24630872-9FB9D1BC-A05F-42A9-BDDF-CFB0042AAB48Q24633167-709D8557-FD54-4CEA-B641-D04654AAE178Q24633254-AE9224F4-3DB8-4BDB-88EA-9E70DED775C8Q24633267-7760FF1C-3F7B-4751-AF01-1AE4C8843C0FQ24633284-191DF251-2D95-4589-9FEC-4E243205062FQ24633301-8672E952-C9C3-48A4-8AB8-6461F783425AQ24633347-180BC090-CCE2-40C3-B87C-BEDF3EC28202Q24633360-64E2F3F2-85E2-4FE3-BB7D-C68A51DA6717Q24633384-DE2A1560-CE71-4759-A429-9FD94CBC0A07Q26801573-B1FC3ADD-A6E7-4552-9E76-FCE4261B5D3FQ26801870-98AB4251-6CE9-446C-841C-26A1ED71C652Q26823903-8E07212A-63FA-4494-B7E6-0D2AE5505FC4Q26824310-020D650B-A355-4EAE-8226-B55AB8EC6C0CQ26824471-35D09136-44C2-49D8-9B44-43D13C3BD8CFQ26827420-94F81A26-0991-4A52-B698-C00F19C7B0D9Q26827571-E23CF44D-520C-438C-B0C7-ABDE5CA3DD99Q26828884-16E08695-93B6-44B4-A96A-D58A6ADE2534Q26863511-33F496AF-72FF-40E6-9D04-5F7BC1735036Q26864111-866774A8-FD20-4238-BA47-FED7EBFEFBF9Q26864247-AC6B4C4C-9566-4B45-89D2-DD28FA197E2CQ26865701-857F0DB0-42AF-4CD4-AB19-22DB83E59BA1Q26865766-270952CB-1A95-4361-90DC-85046E19B6C8Q26991549-857ABC58-A3F7-4A01-9F30-A695C843BD51Q26992321-D175D137-829E-4354-A362-1A8BD0449A81Q26996629-C3544772-FFB4-4D14-A897-B90AA403C5F1Q27002398-B3B159F3-F6EA-448D-BEBA-BCDA66424440Q27002428-3EF883EC-71A2-4FE3-9929-0A9490161092Q27002540-549166F3-66C7-4595-8175-548ADC3E7775Q27005966-C7114860-711A-437B-8E76-E6972EAE2AE2Q27015852-BE7BA00C-AF48-4FD2-941F-3B8ACC7E599B
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vetenskaplig tidskrift
@sv
vědecký časopis
@cs
wetenschappelijk tijdschrift van AlphaMed Press
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Cancérologue
@fr
Oncologist
@ast
Oncologist
@da
Oncologist
@de
Oncologist
@en
Oncologist
@es
Oncologist
@fi
Oncologist
@it
Oncologist
@nb
Oncologist
@nl
type
label
Cancérologue
@fr
Oncologist
@ast
Oncologist
@da
Oncologist
@de
Oncologist
@en
Oncologist
@es
Oncologist
@fi
Oncologist
@it
Oncologist
@nb
Oncologist
@nl
altLabel
The oncologist
@en
prefLabel
Cancérologue
@fr
Oncologist
@ast
Oncologist
@da
Oncologist
@de
Oncologist
@en
Oncologist
@es
Oncologist
@fi
Oncologist
@it
Oncologist
@nb
Oncologist
@nl
P3181
P356
P1055
P1058
P1156
P123
P1250
P1277
P1476
Oncologist
@en
P236
P3181
P356
10.1002/(ISSN)1549-490X
P571
1996-01-01T00:00:00Z